CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Combination of synbiotic and sitagliptin in nonalcoholic fatty liver disease: Is it better than sitagliptin alone?
Yong Kyun Cho
Clin Mol Hepatol. 2018;24(3):299-301.   Published online 2018 September 7    DOI: https://doi.org/10.3350/cmh.2018.1006

Excel Download

Combination of synbiotic and sitagliptin in nonalcoholic fatty liver disease: Is it better than sitagliptin alone?
Yong Kyun Cho
Clinical and Molecular Hepatology. 2018;24(3):299-301   Crossref logo
Link1 Link2 Link3
Combined effects of synbiotic and sitagliptin versus sitagliptin alone in patients with nonalcoholic fatty liver disease
Saba Sayari, Hassan Neishaboori, Maryam Jameshorani
Clinical and Molecular Hepatology. 2018;24(3):331-338   Crossref logo
Link1 Link2 Link3
Efficacy of Sitagliptin on Nonalcoholic Fatty Liver Disease in High-fat-diet-fed Diabetic Mice
Shu-tong Zhou, Wen Cui, Li Kong, Xun Yang
Current Medical Science. 2022;42(3):513-519   Crossref logo
Link1 Link2 Link3
Metabolic dysfunction–associated fatty liver disease predicts new onset of chronic kidney disease better than fatty liver or nonalcoholic fatty liver disease
Marenao Tanaka, Kazuma Mori, Satoko Takahashi, Yukimura Higashiura, Hirofumi Ohnishi, Nagisa Hanawa, Masato Furuhashi
Nephrology Dialysis Transplantation. 2022;38(3):700-711   Crossref logo
Link1 Link2 Link3
Effects of Sitagliptin on Nonalcoholic Fatty Liver Disease in Diet-Induced Obese Rats
Selvihan Beysel Akaslan, Ceyla Konca Degertekin, Guldal Yilmaz, Nuri Cakir, Metin Arslan, Fusun Balos Toruner
Metabolic Syndrome and Related Disorders. 2013;11(4):243-250   Crossref logo
Link1 Link2
The Effect of Lixisenatide and Dapagliflozin in Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus Compared with Sitagliptin and Pioglitazone
ANASTASIOS KOUTSOVASILIS, ALEXIOS SOTIROPOULOS, MARIA PAPPA, DESPINA PAPADAKI, VASILIS KORDINAS, CHARALAMPOS TAMVAKOS, MARIA BOURIKOU, STAVROS BOUSBOULAS, THEODOROS PEPPAS
Diabetes. 2018;67(Supplement_1):   Crossref logo
Link1 Link2
Two are better than one: noninvasive assessment of liver fibrosis in nonalcoholic fatty liver disease
Grace Lai-Hung Wong, Henry Lik-Yuen Chan
Hepatology International. 2015;9(4):481-483   Crossref logo
Link1 Link2 Link3
Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but Higher Risk of Nonalcoholic Fatty Liver Disease Fibrosis Than Men: Summary of the Findings of a Systematic Review and Meta‐analysis
Maya Balakrishnan
Clinical Liver Disease. 2021;18(5):251-254   Crossref logo
Link1 Link2 Link3
Management of nonalcoholic fatty liver disease in children
Jean P. Molleston
Clinical Liver Disease. 2012;1(4):129-130   Crossref logo
Link1 Link2
The Effectiveness of Liraglutide in Nonalcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus Compared to Sitagliptin and Pioglitazone
Takamasa Ohki, Akihiro Isogawa, Masahiko Iwamoto, Mitsuru Ohsugi, Haruhiko Yoshida, Nobuo Toda, Kazumi Tagawa, Masao Omata, Kazuhiko Koike
The Scientific World Journal. 2012;2012:1-8   Crossref logo
Link1 Link2 Link3
This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.